Home An alternative inhibition method for determining cross-reactive allergens
Article
Licensed
Unlicensed Requires Authentication

An alternative inhibition method for determining cross-reactive allergens

  • Yvonne Schmidt-Hieltjes , Malgorzata Teodorowicz , Ad Jansen , Gerco den Hartog , Lisette Elfvering-Berendsen , Nicolette W. de Jong , Huub F.J. Savelkoul and Janneke Ruinemans-Koerts EMAIL logo
Published/Copyright: July 30, 2016

Abstract

Background:

Inhibition assays are an useful tool to identify the allergen of primary sensitization of cross-reactive allergens. Classical ELISA-based inhibition assays are limited by both the availability of commercial standardized allergen extracts and the experience and knowledge needed for making home-made extracts. Moreover the direct comparison of the inhibition ELISAs outcomes between different laboratories is difficult because of different sources of used allergen extracts and a number of methodological variations. Therefore, we propose a novel ImmunoCap (Phadia, Thermofisher Scientific) based immunoinhibition method with the use of commercially available Caps as the allergen source.

Methods:

The novel ImmunoCap based immunoinhibition method was developed and tested with sera from patients with a well-known cross-reactive sensitization for fig (Ficus carica) and ficus (Ficus benjamina). Results were compared with a classically applied inhibition method, i.e. addition of homemade allergen extract to patient serum.

Results:

The amount of allergens (fig and ficus extracts) needed to reach a similar degree of inhibition was comparable for both inhibition methods.

Conclusions:

The ImmunoCap based inhibition assay, in addition to classical inhibition methods, is a valuable tool as the ImmunoCap analyzer and commercial allergens (Caps) are more widely available which makes the outcomes of inhibition tests comparable between different laboratories. Furthermore, in the ImmunoCap inhibition method the same protein source is used for both the inhibition of sIgE and sIgE measurement, which might be even more relevant when multiple cross-reactive allergens are tested.


Corresponding author: Janneke Ruinemans-Koerts, PhD, Department of Clinical Chemistry and Haematology, Rijnstate Hospital, Wagnerlaan 55, 6815 AD Arnhem, The Netherlands, Phone: +31 (0)88-0058888

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Aalberse RC, Akkerdaas J, Van Ree R. Cross-reactivity of IgE antibodies to allergens. Allergy 2001;56:478–90.10.1034/j.1398-9995.2001.056006478.xSearch in Google Scholar

2. De Leon MP, Glaspole IN, Drew AC, Rolland JM, O’Hehir RE, Suphioglu C. Immunological analysis of allergenic cross-reactivity between peanut and tree nuts. Clin Exp Allergy 2003;33:1273–80.10.1046/j.1365-2222.2003.01761.xSearch in Google Scholar

3. Guilloux L, Vuitton DA, Delbourg M, Lagier A, Adessi B, Marchand CR, et al. Cross-reactivity between terrestrial snails (Helix species) and house-dust mite (Dermatophagoides pteronyssinus). II. In vitro study. Allergy 1998;53:151–8.10.1111/j.1398-9995.1998.tb03863.xSearch in Google Scholar

4. Focke M, Hemmer W, Wöhrl S, Götz M, Jarisch R. Cross-reactivity between Ficus benjamina latex and fig fruit in patients with clinical fig allergy. Clin Exp Allergy 2003;33:971–7.10.1046/j.1365-2222.2003.01704.xSearch in Google Scholar

5. Maloney JM, Rudengren M, Ahlstedt S, Bock SA, Sampson HA. The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy. J Allergy Clin Immun 2008;122:145–51.10.1016/j.jaci.2008.04.014Search in Google Scholar

6. Katial RK, Lin FL, Stafford WW, Ledoux RA, Westly CR, Weber RW. Mugwort and sage (Artemisia) pollen cross-reactivity: ELISA inhibition and immunoblot evaluation. Ann Allerg Asthma Immunol 1997;79:340–6.10.1016/S1081-1206(10)63025-6Search in Google Scholar

7. Sharp MF, Stephen JN, Kraft L, Weiss T, Kamath SD, Lopata AL. Immunological cross-reactivity between four distant parvalbumins – Impact on allergen detection and diagnostics. Mol Immunol 2015;63:437–48.10.1016/j.molimm.2014.09.019Search in Google Scholar

8. Van Do T, Hordvik I, Endresen C, Elsayed S. The major allergen (parvalbumin) of codfish is encoded by at least two isotypic genes: cDNA cloning, expression and antibody binding of the recombinant allergens. Mol Immunol 2003;39:595–602.10.1016/S0161-5890(02)00200-6Search in Google Scholar

9. Moneret-Vautrin D-A, Guérin L, Kanny G, Flabbee J, Frémont S, Morisset M. Cross-allergenicity of peanut and lupine: The risk of lupine allergy in patients allergic to peanuts. J Allergy Clin Immunol 1999;104:883–8.10.1016/S0091-6749(99)70303-9Search in Google Scholar

10. Koppelman SJ, de Jong GA, Laaper-Ertmann M, Peeters KA, Knulst AC, Hefle SL, et al. Purification and immunoglobulin E-binding properties of peanut allergen Ara h 6: evidence for cross-reactivity with Ara h 2. Clin Exp Allergy 2005;35: 490–7.10.1111/j.1365-2222.2005.02204.xSearch in Google Scholar PubMed

11. de Leon MP, Glaspole IN, Drew AC, Rolland JM, O’Hehir RE, Suphioglu C. Immunological analysis of allergenic cross-reactivity between peanut and tree nuts. Clin Exp Allergy 2003;33:1273–80.10.1046/j.1365-2222.2003.01761.xSearch in Google Scholar

12. Goetz DW, Whisman BA, Goetz AD. Cross-reactivity among edible nuts: double immunodiffusion, crossed immunoelectrophoresis, and human specific IgE serologic surveys. Ann Allergy Asthma Immunol 2005;95:45–52.10.1016/S1081-1206(10)61187-8Search in Google Scholar

13. Teuber SS, Peterson WR. Systemic allergic reaction to coconut (Cocos nucifera) in 2 subjects with hypersensitivity to tree nut and demonstration of cross-reactivity to legumin-like seed storage proteins: New coconut and walnut food allergens. J Allergy Clin Immunol 1999;103:1180–5.10.1016/S0091-6749(99)70196-XSearch in Google Scholar

14. Jung YG, Cho HJ, Park GY, Min JY, Kim HY, Dhong HJ, et al. Comparison of the skin-prick test and Phadia ImmunoCAP as tools to diagnose house-dust mite allergy. Am J Rhinol Allergy 2010;24:226–9.10.2500/ajra.2010.24.3459Search in Google Scholar PubMed

15. Gadisseur R, Chapelle JP, Cavalier E. A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP(c) 250 with the ImmunoCAP(c) ISAC. Clin Chem Lab Med 2011;49:277–80.10.1515/CCLM.2011.052Search in Google Scholar PubMed

16. Fonseca P, Tavares-Ratado P, Tomaz CT. Interference of Dermatophagoides’ specific immunoglobulins G in the quantification of mite’s specific immunoglobulins E. J Immunoassay Immunochem 2009;30:338–47.10.1080/15321810903084814Search in Google Scholar PubMed

Received: 2016-3-3
Accepted: 2016-6-24
Published Online: 2016-7-30
Published in Print: 2017-2-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Commutable samples with assigned target concentrations may help us harmonise general chemistry results
  4. Reviews
  5. Performance of point-of-care HbA1c test devices: implications for use in clinical practice – a systematic review and meta-analysis
  6. Cardiac troponins and mortality in type 1 and 2 myocardial infarction
  7. Opinion Paper
  8. Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference
  9. Genetics and Molecular Diagnostics
  10. External quality assessment for human papillomavirus 16/18 DNA detection and genotyping in Shanghai, China
  11. General Clinical Chemistry and Laboratory Medicine
  12. Analytical performance of 17 general chemistry analytes across countries and across manufacturers in the INPUtS project of EQA organizers in Italy, the Netherlands, Portugal, United Kingdom and Spain
  13. Commutability of proficiency testing material containing tobramycin: a study within the framework of the Dutch Calibration 2.000 project
  14. Optimization and validation of moving average quality control procedures using bias detection curves and moving average validation charts
  15. Extending laboratory automation to the wards: effect of an innovative pneumatic tube system on diagnostic samples and transport time
  16. Smart management of sample dilution using an artificial neural network to achieve streamlined processes and saving resources: the automated nephelometric testing of serum free light chain as case study
  17. An integrated proteomic and peptidomic assessment of the normal human urinome
  18. An alternative inhibition method for determining cross-reactive allergens
  19. Validation of a new assay for α-synuclein detection in cerebrospinal fluid
  20. Reference Values and Biological Variations
  21. Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year
  22. Cancer Diagnostics
  23. Predictive performance of TPA testing for recurrent disease during follow-up after curative intent surgery for colorectal carcinoma
  24. Cardiovascular Diseases
  25. Mid-regional pro-adrenomedullin (MR-proADM) and mid-regional pro-atrial natriuretic peptide (MR-proANP) in severe aortic valve stenosis: association with outcome after transcatheter aortic valve implantation (TAVI)
  26. Association between apolipoprotein E polymorphisms and premature coronary artery disease: a meta-analysis
  27. Urinary orosomucoid: a novel, early biomarker of sepsis with promising diagnostic performance
  28. Letters to the Editor
  29. CT or MRI
  30. Reply to: CT or MRI in the diagnosis of right lower quadrant abdominal pain?
  31. Quantification of daratumumab in the serum protein electrophoresis
  32. Response to: Interference of daratumumab on the serum protein electrophoresis
  33. Glycated albumin: correlation to HbA1c and preliminary reference interval evaluation
  34. Using “big data” to describe the effect of seasonal variation in thyroid-stimulating hormone
  35. IgE multiple myeloma: a new case report
  36. Therapeutic decision-making process in the intensive care unit: role of biological point-of-care testing
  37. How can we evaluate differences between serial measurements on the same sample? A new approach based on within-subject biological variation
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2016-0172/html
Scroll to top button